S. Kudahetti

发表

The Prognostic Value of PIK3CA Copy Number Gain in Penile Cancer.

D. Berney, Yong-jie Lu, E. Stankiewicz, 2018, Urology.

The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers.

D. Berney, Yong-jie Lu, T. Powles, 2010, The American journal of pathology.

p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer

J. Cuzick, D. Berney, M. Kattan, 2009, BJU international.

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

J. Cuzick, D. Berney, M. Kattan, 2009, British Journal of Cancer.

Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancer.

D. Berney, Yong-jie Lu, G. Cao, 2014, American journal of cancer research.

DNA topoisomerase I and IIα expression in penile carcinomas: assessing potential tumour chemosensitivity

D. Berney, A. Adlan, E. Stankiewicz, 2008, BJU international.

Malignant germ cell tumours in the elderly: a histopathological review of 50 cases in men aged 60 years or over

D. Berney, D. Neal, T. Powles, 2008, Modern Pathology.

The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing

D. Berney, Yong-jie Lu, T. Powles, 2021, Frontiers in Cell and Developmental Biology.

The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis

D. Berney, Yong-jie Lu, Amar S. Ahmad, 2021, Cancers.

Association between large-scale genomic homozygosity without chromosomal loss and nonseminomatous germ cell tumor development.

D. Berney, Yong-jie Lu, A. McIntyre, 2005, Cancer research.

Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.

D. Berney, Yong-jie Lu, D. Lin, 2010, Cancer research.

Chinese and Western prostate cancers show alternate pathogenetic pathways in association with ERG status.

D. Berney, Yong-jie Lu, D. Lin, 2012, American journal of cancer research.

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

D. Berney, Yong-jie Lu, E. Stankiewicz, 2010, Cancer research.

Androgen-Induced TMPRSS 2 : ERG Fusion in Nonmalignant Prostate Epithelial Cells

D. Berney, Yong-jie Lu, E. Stankiewicz, 2010 .

Detection of TMPRSS2:ERG fusion gene in circulating prostate cancer cells.

D. Berney, Yong-jie Lu, B. Young, 2008, Asian journal of andrology.

Detection of TMPRSS 2 : ERG fusion gene in circulating prostate cancer cells

D. Berney, Yong-jie Lu, B. Young, 2008 .

The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer

J. Cuzick, D. Berney, P. Scardino, 2010, Prostate Cancer and Prostatic Diseases.

PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer

D. Berney, Yong-jie Lu, E. Stankiewicz, 2018, PloS one.

Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer

J. Cuzick, D. Berney, P. Scardino, 2017, Scientific Reports.

Identification of ZDHHC14 as a novel human tumour suppressor gene

D. Berney, Yong-jie Lu, D. Lin, 2014, The Journal of pathology.

Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway

D. Berney, Yong-jie Lu, E. Stankiewicz, 2018, Oncotarget.

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort

J. Cuzick, D. Berney, P. Scardino, 2013, British Journal of Cancer.

Absolute Quantitation of DNA Methylation of 28 Candidate Genes in Prostate Cancer Using Pyrosequencing

J. Cuzick, D. Berney, Keqiang Wu, 2011, Disease markers.

HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis

J. Cuzick, D. Berney, L. Ambroisine, 2009, Modern Pathology.

Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of Immunohistochemistry

J. Cuzick, D. Berney, Amar S. Ahmad, 2019, The American journal of surgical pathology.

Immunochemistry for p 16 , but not Rb or p 21 , is an independent predictor of prognosis in conservatively treated , clinically localised prostate cancer

J. Cuzick, D. Berney, M. Kattan, 2015 .

Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer

J. Cuzick, D. Berney, M. Kattan, 2010, Pathology.

Correction: Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells

S. Kudahetti, Xueying Mao, L. Boyd, 2011 .

Non-invasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells.

D. Berney, Yong-jie Lu, J. Shamash, 2019, The Journal of urology.

The potential of brentuximab vedotin, alone or in combination with current clinical therapies, in the treatment of testicular germ cell tumors.

D. Berney, Yong-jie Lu, J. Shamash, 2019, American journal of cancer research.

The retinoblastoma protein/p16INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma

J. Cuzick, D. Berney, L. Ambroisine, 2011, Histopathology.

High‐resolution genome‐wide copy‐number analysis suggests a monoclonal origin of multifocal prostate cancer

D. Berney, Yong-jie Lu, D. Lin, 2012, Genes, chromosomes & cancer.

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer

D. Berney, Yong-jie Lu, J. Shamash, 2023, Frontiers in Oncology.

Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing

J. Cuzick, D. Berney, C. Moore, 2022, BJUI compass.

Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C-ProMeta-1)

D. Berney, Yong-jie Lu, P. Rajan, 2023, BMC Cancer.

The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers.

D. Berney, T. Powles, A. McIntyre, 2010, American Journal of Pathology.

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

D. Berney, E. Stankiewicz, S. Kudahetti, 2010, Cancer research.